Skip to content
healthcare.dev

COMETRIQ

NDC 42388-013, cabozantinib, capsule, from Exelixis, Inc..

Product NDC
42388-013
Status
Listed
Labeler
Exelixis, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203756
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42388-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CABOZANTINIB S-MALATE20 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
42388-013-14423880013144 BLISTER PACK in 1 CARTON (42388-013-14) / 21 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1a0c3bea-c87b-4d25-bb44-5f0174da6b34

Use it

Look up 42388-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42388-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42388-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.